Author response to: OSIN-D-24-00849 Comment on: A novel sequential treatment approach between denosumab and romosozumab in patients with severe osteoporosis.

Saved in:
Bibliographic Details
Title: Author response to: OSIN-D-24-00849 Comment on: A novel sequential treatment approach between denosumab and romosozumab in patients with severe osteoporosis.
Authors: Kumar S; Department of Diabetes & Endocrinology, Westmead Hospital, Westmead Hospital, Cnr Hawkesbury Rd and Darcy Rd, Sydney, 2145 NSW, Australia. shejil.kumar@health.nsw.gov.au.; Faculty of Medicine & Health, University of Sydney, Sydney, Australia. shejil.kumar@health.nsw.gov.au.; Department of Diabetes & Endocrinology, Royal North Shore Hospital, Sydney, Australia. shejil.kumar@health.nsw.gov.au., Gild ML; Faculty of Medicine & Health, University of Sydney, Sydney, Australia.; Department of Diabetes & Endocrinology, Royal North Shore Hospital, Sydney, Australia., McDonald MM; Faculty of Medicine, University of New South Wales, Sydney, Australia.; Bone Biology Program, Garvan Institute of Medical Research, Sydney, Australia., Kim AS; Department of Diabetes & Endocrinology, Westmead Hospital, Westmead Hospital, Cnr Hawkesbury Rd and Darcy Rd, Sydney, 2145 NSW, Australia.; Faculty of Medicine, University of New South Wales, Sydney, Australia.; Bone Biology Program, Garvan Institute of Medical Research, Sydney, Australia., Clifton-Bligh RJ; Faculty of Medicine & Health, University of Sydney, Sydney, Australia.; Department of Diabetes & Endocrinology, Royal North Shore Hospital, Sydney, Australia., Girgis CM; Department of Diabetes & Endocrinology, Westmead Hospital, Westmead Hospital, Cnr Hawkesbury Rd and Darcy Rd, Sydney, 2145 NSW, Australia.; Faculty of Medicine & Health, University of Sydney, Sydney, Australia.
Source: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA [Osteoporos Int] 2024 Oct; Vol. 35 (10), pp. 1871-1872. Date of Electronic Publication: 2024 Aug 09.
Publication Type: Letter; Comment
Journal Info: Publisher: Springer International Country of Publication: England NLM ID: 9100105 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1433-2965 (Electronic) Linking ISSN: 0937941X NLM ISO Abbreviation: Osteoporos Int Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1433-2965
DOI:10.1007/s00198-024-07214-1